(Boursier.com) — BOYDSense SAS, subsidiary ofAlpha MOS, was selected by a jury from the National Union of Medical Technologies Industry (SNITEM) to participate in the 8th edition of the start-up day, organized on April 4, 2023 at the Cité des Sciences. This event brings together all the start-ups linked to Medtech and awards, after a day of conferences and workshops, a jury prize and a public prize, among 12 start-ups.
BOYDSense’s flagship innovation is Lassie, a non-invasive platform for monitoring blood glucose by analyzing exhaled breath, for people with diabetes. This method replaces the micropuncture at the fingertip and thus transforms the monitoring of chronic diseases, thanks to a painless, reliable and compact device.
“We are very proud that our solution is honored on this day, because it durably improves the daily lives of people with diabetes. The health and comfort of people suffering from chronic diseases are at the heart of our priorities. Lassie will be presented to Medtech players on April 4,” said Ben Delhey, CEO of BOYDSense.
The selection of the 12 start-ups was made according to four criteria: the potential of the solution; the potential of the target market; the quality of the team; the proposed business plan.
©2023 Boursier.com